Javascript must be enabled to continue!
Targeting inflammation and mitochondria with dietary linoleic acid for cardiometabolic health when research comes full circle
View through CrossRef
As a new graduate student, I was eager to study the new theory that fish oil rich
in long chain omega 3 fatty acids would be protective against skin cancer due to their
anti-inflammatory properties. Lo and behold, the fish oil diet had some effects on
prostaglandin species but no effect on cancer. Surprisingly, diet rich in linoleic acid
(LA) protected against skin cancer in a dose responsive manner. From this point
forward, I was infected with the bug that biology is complex and not always what you
calculate on paper. Over the 30 years of my career, my lab has evolved to now study how
LA impacts mitochondrial respiration. We conduct our studies based on the solid
knowledge that low levels of LA-rich cardiolipin, e.g., 4-LA cardiolipin, reduce
mitochondrial respiration and therefore, ATP synthesis. Because LA is a required
nutrient that cannot be endogenously synthesized, the diet is the only way to increase
LA, and therefore support 4-LA-cardiolipin turnover in mitochondria. In a mouse model
of middle age, we have discovered that a diet enriched with LA oil increases hind limb
strength and lean mass. Further, we show that LA diet increased 4-LA-cardiolipin and
mitochondrial respiration in skeletal muscle, liver and brown adipose tissue. The
effects occur without changes of markers of inflammation. We have now shown that
fortifying the diets of healthy adults with a modest amount of LA-rich oil also
increases 4-LA-cardiolipin and mitochondrial respiration. The implications of our
findings for cardiometabolic health will be discussed.
American Oil Chemists' Society (AOCS)
Title: Targeting inflammation and mitochondria with dietary linoleic acid for
cardiometabolic health when research comes full circle
Description:
As a new graduate student, I was eager to study the new theory that fish oil rich
in long chain omega 3 fatty acids would be protective against skin cancer due to their
anti-inflammatory properties.
Lo and behold, the fish oil diet had some effects on
prostaglandin species but no effect on cancer.
Surprisingly, diet rich in linoleic acid
(LA) protected against skin cancer in a dose responsive manner.
From this point
forward, I was infected with the bug that biology is complex and not always what you
calculate on paper.
Over the 30 years of my career, my lab has evolved to now study how
LA impacts mitochondrial respiration.
We conduct our studies based on the solid
knowledge that low levels of LA-rich cardiolipin, e.
g.
, 4-LA cardiolipin, reduce
mitochondrial respiration and therefore, ATP synthesis.
Because LA is a required
nutrient that cannot be endogenously synthesized, the diet is the only way to increase
LA, and therefore support 4-LA-cardiolipin turnover in mitochondria.
In a mouse model
of middle age, we have discovered that a diet enriched with LA oil increases hind limb
strength and lean mass.
Further, we show that LA diet increased 4-LA-cardiolipin and
mitochondrial respiration in skeletal muscle, liver and brown adipose tissue.
The
effects occur without changes of markers of inflammation.
We have now shown that
fortifying the diets of healthy adults with a modest amount of LA-rich oil also
increases 4-LA-cardiolipin and mitochondrial respiration.
The implications of our
findings for cardiometabolic health will be discussed.
Related Results
ROLE OF LINOLEIC ACID IN INFANT NUTRITION
ROLE OF LINOLEIC ACID IN INFANT NUTRITION
Four hundred and twenty-eight infants over a 4-year period were studied for approximately 4,000 patient-months of observation while receiving five different milk mixtures varying i...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Dose-dependent production of linoleic acid analogues in food derived Lactobacillus plantarum K25 and in silico characterization of relevant reactions
Dose-dependent production of linoleic acid analogues in food derived Lactobacillus plantarum K25 and in silico characterization of relevant reactions
The objective of this study was to assess and scrutinize the competency of probiotic L. plantarum K25 to produce linoleic acid analogues in the medium supplemented with different c...
Cardiovascular Effects of Dietary Linoleic Acid
Cardiovascular Effects of Dietary Linoleic Acid
A survey is given of the effects of a linoleic-acid-rich diet on arterial thrombosis, blood platelet function and blood pressure in rats and man, and on coronary flow rate and hear...
e0147 Mechanism of different activators of PPARαregulating plasminogen activator inhibitor-1 expression
e0147 Mechanism of different activators of PPARαregulating plasminogen activator inhibitor-1 expression
Objective
To observe the effects of fenofibrate and linoleic acid which was the different activators of PPARα on the expression of PAI-1 and PPARα in HepG2 cells....
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
<b>Periodontal-Cardiometabolic Axis: How Oral Biology Shapes Critical Care Outcomes</b>
<b>Periodontal-Cardiometabolic Axis: How Oral Biology Shapes Critical Care Outcomes</b>
Periodontal disease is among the most prevalent chronic inflammatory diseases globally, that is characterized by unremitting dysbiosis of microbes and destruction of tooth supporti...

